Hospitalist CoverMyMeds Integration: Accelerating Inpatient Medication PAs

The Hospitalist Imperative for Efficient Medication PA

Hospitalists manage a diverse patient cohort with acute conditions, often requiring rapid initiation of complex or high-cost specialty medications. The imperative for quick turnaround times on prior authorizations for these drugs is paramount to avoid treatment delays, ensure continuity of care, and facilitate timely patient discharge.

Optimizing Specialty Drug ePA for Inpatient and Discharge Needs

Klivira's **hospitalist CoverMyMeds integration** streamlines the electronic prior authorization process for medications, directly supporting inpatient internal medicine teams. This includes efficient management of specialty drugs initiated during acute admissions and critical medications required for seamless post-acute care transitions.

Common Medication Prior Authorization Triggers for Hospitalists

• Initiation of high-cost specialty medications (e.g., biologics, novel anticoagulants) during an inpatient stay.
• Medications requiring PA for continuation post-discharge, crucial for preventing care gaps.
• Drugs prescribed for observation status patients that may have specific payer ePA requirements.
• Transition-of-care medications for patients moving to skilled nursing facilities (SNF) or long-term acute care (LTAC).
• Medications for complex cases where off-label use requires specific justification and PA.

Seamless EMR and Payer Workflow Integration

Our platform integrates with leading EMR systems, allowing hospitalists and their care teams to initiate CoverMyMeds ePA requests directly from medication order entry or discharge planning modules. This reduces manual data entry, minimizes administrative burden, and provides real-time status updates within the familiar EMR interface.

Enhanced Data Exchange and Compliance Considerations

• Leverages NCPDP SCRIPT standards for secure, electronic medication PA submissions to payers via CoverMyMeds.
• Supports data exchange via SMART on FHIR where available for deep EMR integration, enhancing clinical context.
• Facilitates adherence to payer-specific clinical criteria for medications, often informed by national guidelines (e.g., AHA/ACC for cardiovascular drugs, IDSA for antimicrobials).
• Ensures all transmissions of PHI adhere strictly to HIPAA regulations during the ePA process.

Impact on Patient Flow and Discharge Readiness

By accelerating medication PA approvals, Klivira empowers hospitalist teams to maintain efficient patient flow and ensure discharge readiness. This mitigates delays caused by pending medication authorizations, supporting timely patient transitions and reducing potential readmissions linked to medication access issues.